MktsMarkets

CytomX Therapeutics, Inc.
NASDAQ: CTMXKey statistics
CTMX News
Stories mentioning CTMX from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 10,258 | 663.00 | 5,963 | 18,658 | 50,917 | 38,093 | 33,432 | 25,115 |
| Cost of Goods Sold | ||||||||
| Gross Profit | ||||||||
| Operating Expenses | ||||||||
| Research & Development | 19,238 | 21,234 | 15,304 | 13,322 | 18,868 | 14,790 | 21,368 | 25,172 |
| Sales General & Admin | ||||||||
| Total Operating Expenses | 29,930 | 28,594 | 21,731 | 19,944 | 28,296 | 20,414 | 29,321 | 33,567 |
| Operating Income (Loss) | (19,672) | (27,931) | (15,768) | (1,286) | 22,621 | 17,679 | 4,111 | (8,452) |
| Interest Income | 1,490 | 1,481 | 1,592 | 1,178 | 955.00 | 1,278 | 1,693 | 1,971 |
| Interest Expense | ||||||||
| Other Expense | (7.00) | (5.00) | 5.00 | 17.00 | 11.00 | (18.00) | (7.00) | (2.00) |
| Pretax Income | (18,189) | (26,455) | (14,171) | (91.00) | 23,587 | 18,939 | 5,797 | (6,483) |
| Tax Provision | 59.00 | 55.00 | 58.00 | 63.00 | 62.00 | 63.00 | 61.00 | 51.00 |
| Net Income (Loss) | (18,248) | (26,510) | (14,229) | (154.00) | 23,525 | 18,876 | 5,736 | (6,534) |
| Earnings Per Share (Basic) | (0.19) | 0.22 | ||||||
| Earnings Per Share (Diluted) | (0.19) | 0.22 | ||||||
| Weighted Average Shares Outstanding (Basic) | 177,273 | 137,936 | 165,004 | 129,076 | 87,122 | 84,439 | 85,093 | 84,881 |
| Weighted Average Shares Outstanding (Diluted) | 177,273 | 137,936 | 165,004 | 129,076 | 87,151 | 84,745 | 85,205 | 84,881 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About CTMX
CytomX Therapeutics, Inc. (NASDAQ: CTMX) is a stock listed on the Nasdaq Stock Market under the ticker symbol CTMX. It last traded at $2.19 (Nov 6, 2026, 4:00 PM ET), up 2.3% on the day. That gives CytomX Therapeutics a market capitalisation of $477.2M.
Over the past 52 weeks CTMX has traded between $2.11 and $8.21.
Revenue for the quarter ended Mar 31, 2026 was $10.3M; a net loss of $18.2M. Revenue was down 79.9% from $50.9M in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $10.3M | -$18.2M | -177.9% |
| Dec 31, 2025 | $663.0K | -$26.5M | -3998.5% |
| Sep 30, 2025 | $6.0M | -$14.2M | -238.6% |
| Jun 30, 2025 | $18.7M | -$154.0K | -0.8% |
From CytomX Therapeutics’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…